ARID1A and PI3-kinase pathway mutations in the endometrium drive epithelial transdifferentiation and collective invasion

Autor: Ben A. Johnson, Mary Rhodes, Jake J. Reske, Amanda L. Patterson, Marie Adams, Mike R. Wilson, José A. Teixeira, Jeanne Holladay, Julie Koeman, Hui Shen, Ronald L. Chandler, Ren-Wei Su, Asgerally T. Fazleabas, Niraj Joshi, Richard Leach, Genna E. Wilber
Jazyk: angličtina
Rok vydání: 2019
Předmět:
0301 basic medicine
ARID1A
General Physics and Astronomy
02 engineering and technology
Haploinsufficiency
Endometrium
Mice
Phosphatidylinositol 3-Kinases
Endometrial cancer
Cell Movement
Loss of Function Mutation
lcsh:Science
Regulation of gene expression
Multidisciplinary
Transdifferentiation
Nuclear Proteins
021001 nanoscience & nanotechnology
Chromatin
Cell biology
DNA-Binding Proteins
Gene Expression Regulation
Neoplastic

medicine.anatomical_structure
Cell Transformation
Neoplastic

Myometrium
Female
0210 nano-technology
Signal Transduction
Epithelial-Mesenchymal Transition
Class I Phosphatidylinositol 3-Kinases
Science
Mice
Transgenic

Biology
General Biochemistry
Genetics and Molecular Biology

Article
Cell Line
03 medical and health sciences
Cancer epigenetics
medicine
Animals
Humans
Neoplasm Invasiveness
Cancer models
PI3K/AKT/mTOR pathway
Gene Expression Profiling
Mesenchymal stem cell
General Chemistry
Epithelium
Endometrial Neoplasms
Gene expression profiling
Disease Models
Animal

030104 developmental biology
lcsh:Q
Transcription Factors
Zdroj: Nature Communications, Vol 10, Iss 1, Pp 1-18 (2019)
Nature Communications
ISSN: 2041-1723
Popis: ARID1A and PI3-Kinase (PI3K) pathway alterations are common in neoplasms originating from the uterine endometrium. Here we show that monoallelic loss of ARID1A in the mouse endometrial epithelium is sufficient for vaginal bleeding when combined with PI3K activation. Sorted mutant epithelial cells display gene expression and promoter chromatin signatures associated with epithelial-to-mesenchymal transition (EMT). We further show that ARID1A is bound to promoters with open chromatin, but ARID1A loss leads to increased promoter chromatin accessibility and the expression of EMT genes. PI3K activation partially rescues the mesenchymal phenotypes driven by ARID1A loss through antagonism of ARID1A target gene expression, resulting in partial EMT and invasion. We propose that ARID1A normally maintains endometrial epithelial cell identity by repressing mesenchymal cell fates, and that coexistent ARID1A and PI3K mutations promote epithelial transdifferentiation and collective invasion. Broadly, our findings support a role for collective epithelial invasion in the spread of abnormal endometrial tissue.
PIK3CA mutations and ARID1A loss co-exist in endometrial neoplasms. Here, the authors show that these co-mutations drive gene expression profiles correlated with differential chromatin accessibility and ARID1A binding in the endometrial epithelium, resulting in partial EMT and myometrial invasion.
Databáze: OpenAIRE